Browsing Tag
psilocybin
4 posts
What NPX-5’s Phase IIb trial means for the future of oncology-linked mental health treatments
NPX-5 enters Phase IIb trials for cancer-related mental health. Discover what this means for biotech strategy, regulation, and future treatments.
Why a former Alaska Airlines pilot tried to cut off a plane’s engines midair—and what the court decided
Find out how a former Alaska Airlines pilot’s midair engine shutdown attempt became a landmark mental health and aviation safety case.
Can short-acting psychedelics solve the scalability problem in depression treatment?
Short-acting psychedelics like bretisilocin could reshape mental health treatment. Can they overcome the clinical bottlenecks faced by psilocybin and ketamine?
Usona Institute gets FDA breakthrough status for psilocybin in MDD
Wisconsin-based Usona Institute has been granted breakthrough therapy designation for psilocybin from the US Food and Drug Administration…